J&K CDF amended for medical aid
Analysis based on 6 articles · First reported Jul 06, 2026 · Last updated Jul 06, 2026
The policy is unlikely to have significant market impact as it involves a relatively small allocation from existing CDF funds. It may marginally benefit healthcare providers in Jammu and Kashmir by increasing patient inflow for expensive treatments.
The Government of Jammu and Kashmir amended the Constituency Development Fund (CDF) Scheme guidelines on July 6, 2026, allowing Members of the Legislative Assembly (MLAs) to allocate up to ₹20 lakh annually from their CDF for medical assistance to patients from Below Poverty Line (BPL) families and other economically weaker categories. The assistance covers organ transplantation (up to ₹5 lakh), cancer treatment (up to ₹2.75 lakh), and chronic kidney disease requiring dialysis (up to ₹1 lakh), among other notified diseases. Payments are made directly to empanelled hospitals after patients exhaust benefits under existing schemes like PM-JAY SEHAT, Medical Aid Trust, and Cancer Treatment and Management Fund for Poor. The amendment aims to provide financial relief to poor patients with life-threatening ailments while ensuring transparency and preventing misuse.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard